Priya J. Bansal, M.D.,
NPI 1811970486ActiveIndividual· Allergy & Immunology· Saint Charles, IL
Allergy & Immunology (M.D.,) in Saint Charles, Illinois, licensed in IL, with an NPI issued in November 2005. Their prescriptions cost Medicare Part D more than their services did: $1,451,491 for 999 claims, against $334,524 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 34 companies reporting payments in 2025, $358,413 in all, mostly speaking and faculty fees. Lists Northwestern Medicine Central Dupage Hospital and 1 other hospital as hospital affiliations.
Overview
| NPI | 1811970486 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D., |
| Sole proprietor | No |
| NPI issued | Nov 28, 2005 |
| Last updated in NPPES | Feb 20, 2023 |
| Certified by provider | Feb 20, 2023 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Allergy & Immunology Primary | 207K00000X | 036103919 | IL |
| Allergy & Immunology, Allergy | 207KA0200X | 036103919 | IL |
| Internal Medicine, Allergy & Immunology | 207RA0201X | 036103919 | IL |
| Pediatrics, Pediatric Allergy/Immunology | 2080P0201X | 036103919 | IL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Allergy/Immunology (IL) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 140 |
|---|---|
| Services billed | 13,465 across 31 procedure codes |
| Paid by Medicare | $334,524 |
Part D prescriptions in 2024
| Prescriptions (claims) | 999 · 1,730 30-day fills |
|---|---|
| Patients | 145 |
| Total drug cost | $1,451,491 |
| Generic share | 55% of claims |
Education and affiliations
| Graduation year | 1998 |
|---|---|
| Medicare specialty | Allergy/Immunology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Hospital affiliations
Industry payments (Open Payments)
- 2025$358,413 · 520 payments from 34 companies
- 2024$220,003 · 462 payments from 26 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $76,191 | 110 |
| Regeneron Healthcare Solutions, Inc. | $56,623 | 45 |
| Novartis Pharmaceuticals Corporation | $40,780 | 41 |
| Csl Behring | $40,201 | 52 |
| Lilly USA, LLC | $37,646 | 44 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$232,582 · 79 payments
- Consulting Fee$78,823 · 26 payments
- Travel and Lodging$36,275 · 144 payments
- Food and Beverage$9,004 · 266 payments
- Honoraria$1,639 · 2 payments
- Education$89.26 · 3 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records